Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Anagenics ( (AU:AN1) ) is now available.
Anagenics Limited has announced the cessation of 3,500,000 options with an exercise price of $0.032, which expired on 5 April 2026 without being exercised. The expiry of these options marginally reduces the company’s potential future share dilution, slightly clarifying the capital structure for existing shareholders and potential investors.
The notification, lodged as an Appendix 3H with the ASX, confirms the formal removal of these unexercised options from Anagenics’ issued capital as of 17 April 2026. While operational details are unchanged, the update underscores routine capital management and may signal that the market price did not justify exercising the options before expiry.
More about Anagenics
Anagenics Limited, listed on the ASX under the code AN1, operates in the broader life sciences and biotechnology investment space, though this specific filing focuses on its capital structure rather than detailing its products or services. The company regularly reports changes to its issued capital to maintain transparency for shareholders and the market.
Current Market Cap: A$5.91M
See more data about AN1 stock on TipRanks’ Stock Analysis page.